Portfolio 2 Investments
NRG Therapeutics
biotechnology, neuroscience, pharmaceuticals
series-b
€50 M
Sep 2025
Investor
Artios
biotechnology, pharmaceuticals, healthcare
series-d
€115 M
Nov 2025
Investor